Table 2 Capillaroscopy results in ALS patients and controls.

From: Microvascular abnormalities in skin capillaries of individuals with amyotrophic lateral sclerosis

 

Control, n = 35

ALS, n = 28

p-value

OR [ 95%CI]

Capillary density, Median [Q1, Q3]

7.00 [7.00, 8.00]

7.00 [6.75, 8.00]

0.761

 

Capillary diameter, Median [Q1, Q3]

8.72 [8.00, 10.00]

10.15 [8.50,12.06]

0.0111

 

Dilated capillary, n (%)

4 (11.43%)

5 (17.8%)

0.492

1.68 [0.40, 7.48]

Avascular zones, n

0 (0.00%)

0 (0.00%)

 > 0.992

 

Tortuosity, n (%)

 < 0.0012

1.89 [0.66, 5.54]

 Without

6 (17.14%)

0 (0.00%)

 

 Mild

18 (51.43%)

13 (46.43%)

 Moderate

10 (28.57%)

5 (17.86%)

 Severe

1 (2.86%)

10 (35.71%)

Ramified capillaries, n (%)

4 (11.43%)

13 (46.43%)

0.0023

6.72 [2.00, 27.19]

Micro-hemorrhages, n (%)

0 (0.00%)

3 (10.71%)

  

Thrombosis, n

0 (0.00%)

0 (0.00%)

 > 0.992

 

Sub-papillary venous plexus, n (%)

34 (97.14%)

27 (96.43%)

 > 0.992

 
  1. Fisher exact test to calculate p-value; univariant logistic models to calculate odds ratio (OR).
  2. CI confidence interval.
  3. 1Wilcoxon test.
  4. 2Fisher exact test; univariant logistic models to calculate odds ratio (OR).